1 / 14

Acute Myeloid Leukaemia

Acute Myeloid Leukaemia. Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH. Acute Myeloid Leukaemia. Definition - It is a clonal malignant disease, in which there is maturation arrest of the haemopoietic precursors at an early stage of development

nedaa
Download Presentation

Acute Myeloid Leukaemia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acute Myeloid Leukaemia Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH

  2. Acute Myeloid Leukaemia • Definition - It is a clonal malignant disease, in which there is maturation arrest of the haemopoietic precursors at an early stage of development - It is characterized by the presence of > 20% blasts in the bone marrow

  3. Acute Myeloid Leukaemia • Pathophysiology - The activation of abnormal genes through chromosomal translocations and other abnormalities - Exposure to radiation e.g. high incidence of leukaemia among survivors of the atomic bomb in Japan - Past exposure to chemotherapy: Alkylating agents Topoisomerase II inhibitors - Antecedent haematological disorders: myelodysplastic syndrome myeloproliferative disease e.g. CML

  4. Myelodysplastic Syndrome • A group of clonal disorders that are characterized by progressive cytopenias and dysplasia • Occurs mainly in elderly patients • The more severer forms ultimately progress to acute leukaemia • Usuaaly associated with chromosomal abnormalities in a large proportion of cases

  5. Acute Myeloid Leukaemia • FAB classification MO AML with minimal differentiation M1 AML without maturation M2 AML with maturation M3 Acute promyelocytic leukaemia M4 Acute myelomonocytic leukaemia M5a Acute monoblastic leukaemia b M6 Erythroleukaemia M7 Acute megacaryoblastic leukaemia

  6. Acute Myeloid Leukaemia • Presentation - Anaemia, bleeding and/or repeated infections - Organ/skin infiltration specially in M5 - DIC specially in AML, M3 - Hyperleukostasis (headache, dizziness, blurring of vision)

  7. Acute Myeloid Leukaemia • Lab work up - CBC and peripheral smear examination - P.T., APTT, fibrinogen & D-dimers - LDH, uric acid - Urea and electrolytes - LFT - Blood cultures

  8. Acute Myeloid Leukaemia • Lab work up Bone marrow aspiration and trephine biopsy for: - Morphology - Cytochemical stains - Immunophenotyping - Cytogenetic analysis

  9. Acute Myeloid Leukaemia • Other investigations - Chest X-ray - ECG - MGA scan (cardiac toxicity of anthracycline chemotherapeutics)

  10. Acute Myeloid Leukaemia • Prognostic criteria Cytogenetic abnormalities are the single most important prognostic factors in AML. - Good prognostic abnormalities: M3 t(15, 17) M2 t(8,21) M3 inv(16) - Poor prognostic abnormalities Monosomy 7 Monosomy 5

  11. Acute Myeloid Leukaemia Management • Induction and consolidation - Combination of Anthracycline & Ara-C - A total of 3 to 5 courses • Late intensification - High dose Ara-C in young good risk group - Matched All-BMT in fit, bad risk fit - Mini-allo BMT or autologus BMT in older patients

  12. Acute Myeloid Leukaemia • Management - About 50% of patients achieve CR after first course - Another 10% enter remission after 2nd course

  13. Acute Promyelocytic Leukaemia • Clinical presentation - Younger age on presentation as compared to other AML subtypes - Often patients have low counts on presentation - Bone marrow has >30% promyelocytes - It is commonly associated with DIC which is the main reason for early deaths - Aggressive replacement with platelets and cryoprecipitate is the mainstay of early management

  14. Acute Promyelocytic Leukaemia • T(15,17) is a good prognostic indicator and is present in 95% of cases • This translocation involves the retinoic acid receptor gene rendering the tumor cells susceptible to all-trans retinoic acid (ATRA) • CR achieved in >90% of cases with ATRA and chemotherapy

More Related